T3D Therapeutics, Inc. planned to raise $18.00 M. So far, they have raised $ 6.00 M. The first sale took place on 02 March 2018. There was no minimum investment amount for this issue.
1 investors have participated in this issuance.
The amount is being raised through the issue of Equity.
T3D Therapeutics, Inc., a Corporation incorporated in DELAWARE, filed a new Form D on 12 March 2018 announcing this fund raise. It listed its industry as Pharmaceuticals.
Date of filing: 12 March 2018
Type of filing: New
Offering size: 18,000,000 USD
Amount Raised: 6,000,000 USD
Type of security: Equity
Registration Exemptions: 06b
T3D Therapeutics, Inc. is a Corporation incorporated in the state of DELAWARE.
|Central Index Key||0001579600|
|Incorporation Year||More than 5 years ago|
|Address||68 TW Alexander Drive, None, Research Triangle Park, NC 27709|
|Previously Known As|
|Revenue Range||Decline To Disclose|
|Aggregate Net Asset Value Range||Decline To Disclose|
The issuer has disclosed 5 executives, directors and promoters.
Name: John Didsbury
Designation: Executive Officer, Director, Promoter
Name: Charles Lineberry
Name: Barry Buzogany
Name: John Golden
Name: Tom Mendell